HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karin N Westlund Selected Research

Macrophage Migration-Inhibitory Factors

1/2016Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.
1/2015Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karin N Westlund Research Topics

Disease

22Pain (Aches)
12/2021 - 02/2003
18Inflammation (Inflammations)
03/2021 - 01/2000
12Hypersensitivity (Allergy)
03/2021 - 01/2002
11Neuralgia (Stump Neuralgia)
12/2021 - 08/2012
10Pancreatitis
03/2021 - 02/2003
5Hyperalgesia
12/2017 - 01/2002
5Arthritis (Polyarthritis)
01/2013 - 01/2000
4Visceral Pain
03/2018 - 02/2003
4Tics (Tic)
01/2018 - 01/2016
3Chronic Pain
12/2021 - 01/2017
3Trigeminal Nerve Injuries
12/2020 - 01/2018
3Chronic Pancreatitis
11/2014 - 02/2003
3Joint Diseases (Joint Disease)
01/2013 - 09/2005
2Neoplasms (Cancer)
09/2006 - 09/2005
1Atrophy
03/2021
1Spontaneous Remission
03/2021
1Fibrosis (Cirrhosis)
03/2021
1Experimental Arthritis
01/2020
1Neuroblastoma
01/2020
1Edema (Dropsy)
05/2017
1Facial Pain (Myofacial Pain)
01/2016
1Cystitis
01/2016

Drug/Important Bio-Agent (IBA)

5Opioid Analgesics (Opioids)IBA
12/2021 - 09/2004
5Pharmaceutical PreparationsIBA
03/2020 - 01/2002
5Glutamic Acid (Glutamate)FDA Link
01/2020 - 01/2000
5Morphine (MS Contin)FDA LinkGeneric
01/2015 - 02/2003
3Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2015
3Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2015 - 01/2000
3Complementary DNA (cDNA)IBA
08/2012 - 10/2007
3EnkephalinsIBA
03/2008 - 10/2007
2Peptides (Polypeptides)IBA
12/2021 - 01/2016
2CeruletideIBA
03/2021 - 01/2004
2N-Methylaspartate (NMDA)IBA
01/2020 - 01/2018
2Pioglitazone (Actos)FDA Link
01/2018 - 12/2017
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2018 - 12/2017
2salicylhydroxamic acid (SHAM)IBA
01/2018 - 08/2012
2PPAR gammaIBA
01/2018 - 12/2017
2protease-activated receptor 4IBA
05/2017 - 01/2016
2HMGB1 Protein (HMG1)IBA
05/2017 - 01/2016
2preproenkephalinIBA
01/2016 - 02/2008
2Macrophage Migration-Inhibitory FactorsIBA
01/2016 - 01/2015
2Analgesics (Analgesic Drugs)IBA
11/2014 - 09/2004
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2012 - 06/2009
2Type I Tumor Necrosis Factor ReceptorsIBA
07/2012 - 06/2009
2KaolinIBA
08/2010 - 01/2002
2CarrageenanIBA
08/2010 - 01/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 06/2009
2CalciumIBA
08/2009 - 09/2006
2Protons (Proton)IBA
06/2009 - 09/2005
2beta-Galactosidase (Lactaid)IBA
02/2008 - 10/2007
2dibutyldichlorotinIBA
10/2007 - 02/2003
2BradykininIBA
09/2004 - 03/2003
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2004 - 03/2003
2Excitatory Amino Acid AntagonistsIBA
01/2004 - 03/2003
1Single-Chain AntibodiesIBA
12/2021
1AntibodiesIBA
12/2021
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
12/2021
1Calcium Channels (Calcium Channel)IBA
12/2021
1Fast GreenIBA
03/2021
1Acetylcarnitine (Alcar)IBA
03/2021
1ManganeseIBA
12/2020
1ELB00824IBA
03/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020
1NR1 NMDA receptorIBA
01/2020
1daidzeinIBA
01/2020
1lavendustin AIBA
01/2020
1lavendustin BIBA
01/2020
1GenisteinIBA
01/2020
1PPAR-gamma AgonistsIBA
01/2019
1ElementsIBA
03/2018
1VorinostatFDA Link
01/2018
1Histone Deacetylase InhibitorsIBA
01/2018
1entinostat (MS 275)IBA
01/2018
1Cycloserine (Seromycin)FDA Link
01/2018
1Drug CombinationsIBA
01/2018
1Histone Deacetylases (Histone Deacetylase)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
12/2017
1FPS-ZM1IBA
05/2017
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
05/2017
1Sulfhydryl Compounds (Thiols)IBA
05/2017
1Toll-Like Receptor 4IBA
05/2017
1DisulfidesIBA
05/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2017
1Antidepressive Agents (Antidepressants)IBA
01/2017
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2017
1Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2017
1Carrier Proteins (Binding Protein)IBA
01/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016
1ChromatinIBA
01/2016

Therapy/Procedure

5Therapeutics
12/2020 - 03/2003
4Intraperitoneal Injections
12/2021 - 01/2004
3Analgesia
11/2014 - 03/2008
2Sutures (Suture)
05/2020 - 12/2012
2Aftercare (After-Treatment)
01/2020 - 01/2015
1Injections
03/2021
1Oral Surgery (Maxillofacial Surgery)
04/2020
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Intravesical Administration
05/2017